NYSE · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · LARGE CAP
Medtronic PLC MDT
14 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY13 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$36.4B
▲ 8.4% vs FY2024
Dividend streak
13 yrs
Raised every year since 2013
EPS · FY25
$3.73
Dividend / sh · FY25
$2.84
Payout · FY25
76%
ROE · FY25
9.8%
Net margin · FY25
13.2%
Dividend coverage
1.3×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 36.4B
Revenue, FY2025 · full 14-year series below
Revenue
Net income
13 cents of every revenue dollar became profit this year.
Per share
USD 3.73
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 1.3 times — the rest stayed in the company.
Profitability
9.8%
Return on equity, FY2025
ROE
Operating margin17.8%
Net margin13.2%
Return on assets5.2%
Each USD of equity produced 10 cents of profit this year.
Returned to shareholders
USD 4.2B
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 3.6B
Net buybacksUSD 519.0M
Share of profit86.6%
Consecutive raises13 years
USD 3.6B in dividends and USD 519.0M in buybacks — 87% of the year's profit went back to shareholders.
Growth
+3.8% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+5.2%
+3.8%
+2.3%
Net income
+8.5%
+5.9%
+3.1%
EPS, diluted
+9.8%
+7.0%
+4.2%
Dividend / share
+1.4%
+4.1%
+6.5%
Returned to shareholders
−0.8%
+2.0%
−1.8%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
1.28B
Shares outstanding, FY2025
Change, 5 years−4.8%
Change, 10 years−8.5%
The share count shrank 5% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 93.0B
total assets, end of FY2025
Total assetsUSD 93.0B
EquityUSD 49.5B
CashUSD 1.9B
Gross debtUSD 28.0B
Net debtUSD 26.0B
Current ratio2.13×
Net debt stands at 53% of equity.
History
14 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Revenue $B
36.4
33.5
32.4
31.2
31.7
30.1
28.9
30.6
30.0
29.7
28.8
20.3
17.0
16.6
Operating income $B
6.5
6.0
5.1
5.5
5.8
4.5
4.8
6.3
6.6
5.4
5.4
3.8
3.8
4.4
EBITDA $B
9.4
8.8
7.8
8.2
8.5
7.2
7.5
8.9
9.3
8.3
8.2
5.1
4.7
5.2
Income tax $B
1.3
0.9
1.1
1.6
0.5
0.3
−0.8
0.5
2.6
0.6
0.8
0.8
0.6
0.8
Net income $B
4.8
4.7
3.7
3.8
5.0
3.6
4.8
4.6
3.1
4.0
3.5
2.7
3.1
3.5
EPS, diluted $
3.73
3.61
2.76
2.82
3.73
2.66
3.54
3.41
2.27
2.89
2.48
2.41
3.02
3.37
Dividend / sh $
2.84
2.80
2.76
2.72
2.52
2.32
2.16
2.00
1.84
1.72
1.52
1.22
1.12
1.04
Payout %
76
77
100
96
67
87
60
58
80
59
60
50
36
30
ROE %
9.8
9.5
7.2
7.2
9.7
7.1
9.5
9.2
6.2
7.9
6.7
7.4
16.1
18.6
Shares out B
1.28
1.28
1.31
1.33
1.33
1.35
1.34
1.34
1.35
1.37
1.40
1.42
1.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
45 of 45
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed